ArticleOncotarget2016

Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.

Sujit Suklabaidya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.